News | October 08, 2024
AstraZeneca, CSPC Pharmaceutical agree for a pre-clinical novel lipid-lowering therapy
CSPC will receive an upfront payment of $100 million from AstraZeneca
CSPC will receive an upfront payment of $100 million from AstraZeneca
The OPTASE range is a safe, tested and expert recommended 3-step regime to help tackle the cause and symptoms of eye conditions
Lamotrigine extended-release tablets are indicated for adjunctive therapy for primary generalized tonic-clonic seizures and partial-onset seizures
Grant funding from the Bill & Melinda Gates Foundation will support the rapid and efficient design and synthesis of novel small molecules
Sun Pharma will have the exclusive worldwide rights to commercialise Fibromun
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
Apulki Healthcare is India's first PPP dedicated for cancer and cardiac care hospita
Global survey reveals top workforce concerns, evolving strategic priorities, and key technology investment areas for life sciences manufacturers
The samples of both products mentioned in the CDSCO list are spurious and not manufactured by Alkem
Subscribe To Our Newsletter & Stay Updated
